TY  - CHAP
M1  - Book, Section
TI  - Hypertrophic Cardiomyopathy – Updated June 2023
A1  - Lorenzini, Massimiliano
A1  - Elliott, Perry M.
A2  - Fuster, Valentin
A2  - Narula, Jagat
A2  - Vaishnava, Prashant
A2  - Leon, Martin B.
A2  - Callans, David J.
A2  - Rumsfeld, John S.
A2  - Poppas, Athena
Y1  - 2022
N1  - 
T2  - Fuster and Hurst's The Heart, 15e
AB  - Content  UpdateIMPROVE-HCM  Trial:  A  Safe  Novel  Agent  for  Nonobstructive  Hypertrophic  CardiomyopathyNinerafaxstat  targets  cardiac  fatty  acid  metabolism  with  the  goal  of  improving  energetics  in  those  with  nonobstructive  hypertrophic  cardiomyopathy  (HCM).  Read  More  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2025/01/23
UR  - accesscardiology.mhmedical.com/content.aspx?aid=1207967195
ER  -